Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
executive pay
Pharma
Vertex raises pay of CEO Reshma Kewalramani by 4% to $21.5M
After a year that included a 12% jump in revenue, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million.
Kevin Dunleavy
Apr 9, 2025 5:45am
The 15 highest paid pharma CEOs of 2021
Jun 27, 2022 3:00am
'The Top Line': M&A lull, highest paid R&D execs and more
May 13, 2022 6:13am
Vertex's CEO scored a major pay bump in 2021
Apr 8, 2022 11:10am
Viatris investors displeased with exec pay
Jan 6, 2022 9:50am
Shareholder groups target Regeneron's CEO, CSO compensation
Jun 9, 2021 11:13am
